Scientific Study Reveals Inaccuracies in Smartwatch Calorie Tracking
Quick Brief
Recent scientific research highlights significant inaccuracies in how smartwatches measure calorie burn during physical activity. Evaluating four major brands, studies indicate that users cannot fully trust these health metrics, with Garmin showing the least accurate performance.
What Happened?
Scientific analyses and academic institutions, including Florida International University, have highlighted inaccuracies in health data reported by smartwatches. Specifically, evaluations covering four major brands demonstrated that Garmin performed the worst in calculating workout calorie expenditure.
Why It Matters
Millions of people rely on wearable fitness technology to monitor their daily health, diet, and exercise routines. Inaccurate calorie calculations can misinform users about their actual energy expenditure and metabolic health progress.
Key Facts
- Scientific studies reveal that smartwatches are unreliable for tracking workout calorie burn.
- Four major smartwatch brands were evaluated in the recent health data analysis.
- Garmin performed the worst among the four tested brands regarding calorie accuracy.
- Research originates from sources including Florida International University and technology publications.
Compiled from 1 outlet
Related Stories
New Zealand Approves MDMA Treatment for Severe PTSD
New Zealand's drug regulatory body, Medsafe, has granted approval for two psychiatrists to prescribe pharmaceutical-grade MDMA for severe post-traumatic stress disorder. This decision makes New Zealand the second country globally to approve the psychedelic substance for therapeutic use, following Australia's similar authorization in 2023.
Roche to Expand Testing Capacity Amid Congo Ebola Outbreak
Roche Holding AG is deploying new laboratory equipment to the epicenter of the Democratic Republic of Congo's Ebola epidemic. The move comes as health authorities face ongoing challenges in containing a virus that has repeatedly outpaced the local response. The expansion aims to bolster diagnostic capabilities in the heavily affected Ituri region.
Psilocybin Found to Prevent Chemotherapy-Induced Nerve Damage in Preclinical Models
Recent research reveals that psilocybin may protect against a common and debilitating side effect of cancer treatment. Preclinical models demonstrate that the compound can prevent nerve damage and associated symptoms caused by chemotherapy. This discovery highlights potential new therapeutic applications for the psychedelic substance.
Reports Indicate Intervention to Delay or Exclude Measles Deaths from CDC Tallies
Recent reports indicate that intervention by officials, including the new CDC director appointed by Trump, led to a delay or exclusion of measles-related deaths from official CDC tallies. Meanwhile, investigations involving specific cases, such as in Pennsylvania and Lancaster, are underway.